Updates in Drug Treatment of Severe Hypertriglyceridemia.
Journal Information
Full Title: Curr Atheroscler Rep
Abbreviation: Curr Atheroscler Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflicts of InterestI. Gouni-Berthold has received personal honoraria for consulting from Amgen, Regeneron, Aegerion, Akcea Therapeutics, Daiichi-Sankyo, Novartis, Sanofi, Ultragenyx, and Amarin. H.K. Berthold and J. Schwarz have no conflicts of interest to disclose. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflicts of Interest I. Gouni-Berthold has received personal honoraria for consulting from Amgen, Regeneron, Aegerion, Akcea Therapeutics, Daiichi-Sankyo, Novartis, Sanofi, Ultragenyx, and Amarin. H.K. Berthold and J. Schwarz have no conflicts of interest to disclose."
"Funding Open Access funding enabled and organized by Projekt DEAL."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025